Retatrutide 20mg UK: Dosing Protocols, Phase 2 Results & How to Order
Retatrutide 20mg UK is the most widely purchased Retatrutide format for initial and standard research protocols. This article covers the dosing science, what Phase 2 data shows at lower dose levels, and how to order the 20mg pen from Alluvi Healthcare.
Understanding Retatrutide 20mg
The Retatrutide 20mg pen provides 20mg of research-grade Retatrutide per pen. In Phase 2 clinical trial context, dosing was weekly, starting from 1mg and escalating to maximum doses of up to 12mg over 24 weeks. The 20mg pen provides sufficient compound for extended multi-week research protocols at standard doses.
Phase 2 Dose-Response Data
- 2mg weekly: Dose escalation starting point in Phase 2 protocol
- 4mg weekly: ~17.3% weight reduction at 48 weeks
- 8mg weekly: ~19.7% weight reduction at 48 weeks
- 12mg weekly (maximum): ~22.5% weight reduction — mean 18.3kg over 48 weeks
Even at doses well below maximum, Retatrutide produced clinically significant weight reduction — more than semaglutide at any approved dose.
Retatrutide 20mg vs 40mg Pen: Which Format?
The decision between 20mg and 40mg formats depends on your research timeline and consumption rate:
- 20mg pen: Lower entry cost, suitable for introductory protocols or shorter durations
- 40mg pen (£189.99): Better value per milligram for extended programmes; fewer reorder cycles
Both formats are available at alluvistore.co.uk. For bulk pricing on either format, contact [email protected].
Side Effect Profile in Phase 2 Trials
The tolerability profile of Retatrutide in Phase 2 was broadly consistent with GLP-1 class medications. The most commonly reported adverse events were gastrointestinal in nature — nausea (most common during dose escalation), vomiting, diarrhoea and decreased appetite. These were predominantly mild-to-moderate and transient, decreasing in frequency after the escalation phase.
“Gastrointestinal events were more common with retatrutide than placebo but were generally mild-to-moderate in severity and occurred predominantly during the dose-escalation period.” — NEJM Phase 2 Report
How to Order Retatrutide 20mg UK
Visit alluvistore.co.uk, select the Retatrutide 20mg pen, proceed to checkout, and complete the R&D confirmation. Our support team emails payment instructions (crypto or bank transfer) within 1–2 hours. UK orders typically arrive within 2–5 working days. Use ALLUVI10 for 10% off.
Buy Retatrutide 20mg
🛒 Shop the 20mg pen now · ❓ Dosing & research FAQs · 📦 Check my orders
Order Retatrutide 20mg UK
Standard and high-dose Retatrutide pens in stock. UK dispatch, batch tested, discreet packaging.
Buy Retatrutide 20mg Research FAQs- Retatrutide Phase 2 Dose Escalation Data — NEJM 2023 New England Journal of Medicine
- Retatrutide — ClinicalTrials.gov Registry ClinicalTrials.gov
- GLP-1 Agonist Pharmacology — PubMed Review PubMed / NCBI
- MHRA: Medicines Regulation Overview MHRA / GOV.UK